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a b s t r a c t
Diabetes mellitus is a well-recognized cause of male sexual dysfunction and impairments of male fertility.
Streptozotocin (STZ) is used for medical treatment of neoplastic islet -cells of pancreas and producing of
animal model of diabetes mellitus type 1 that is characterized by suppression of reproductive activity due
to the hyperglycaemia-induced oxidative stress and histopathological alterations in testes. Seeking for
the agents that could alleviate diabetes-induced damage to reproductive system is yet the important area
of inquiry. The present study was designed to evaluate whether hydrated C60 fullerene (C60HyFn), which
is known to be powerful bioantioxidant, eliminate testicular dysfunction induced by STZ-diabetes in rats.
Wistar strain male albino rats were divided into four groups of six animals each: (1) control group, (2)
C60HyFn-treated nondiabetic group, (3) STZ-diabetic group and (4) C60HyFn-treated diabetic group. Once
hyperglycaemia was induced by STZ, rats in the second and fourth groups were treated with C60HyFn (in
the form of drinking water) at the dose of 4 g/kg daily for 5 weeks. In diabetic rats, relative weights of
right cauda epididymis, seminal vesicles, prostate, sperm motility and epididymal sperm concentration
were significantly less than those of control group, but which were restored in the fourth group treated
with C60HyFn (p < 0.001). In hematoxylin and eosin staining, marked histopathological changes including
degeneration, desquamation, disorganisation and reduction in germinal cells, interstitial oedema and
congestion were evident in the testis of diabetic rats, but C60HyFn treatment resulted in recovery of
histopathological changes and an increase in Johnsen’s testicular score significantly (p < 0.001). C60HyFn
treatment restores the increased apoptosis induced by STZ-diabetes. In diabetic rats, levels of serum
testosterone, testicular reduced glutathione (GSH) and alpha-tocopherol were significantly reduced and
testicular lipid peroxidation level was increased (p < 0.001). Nevertheless, treatment of diabetic rats with
C60HyFn resulted in significant corrective effects on these parameters towards the control levels. C60HyFn,
applied alone, did not exert any toxic effects in testicular tissues. Furthermore, C HyFn treatment in60
diabetic and nondiabetic rats resulted in considerable elevations of some important polyunsaturated
fatty acids. In conclusion, we have presented for the first time substantial evidence that administration
of C60HyFn significantly reduce
testicular dysfunction and spe
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1. IntroductionStreptozotocin (STZ) has long been used as a tool for creating
experimental diabetes in animal. An advantage of the STZ-model
is that it closely mimics type 1 diabetes in humans rather than
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ytotoxic effect STZ is used for treating metastatic cancer of the
ancreatic islet cells. While it carries a substantial risk of toxicity
nd rarely cures the cancer, its use is generally limited to patients
hose cancer cannot be removed by surgery (Brentjens and Saltz,
001). STZ was found to be selectively toxic to the -cells of the pan-
reatic islets, the cells that normally regulate blood glucose levels
y producing the hormone insulin. Therefore, the main symptom
f STZ intoxication is hyperglycaemia causing short and long term
iabetic complications (Brownlee, 2005). It is well recognized that
iabetes-induced hyperglycaemia leads to oxidative stress caused
y impairment of mitochondrial electron transfer and activation of
he polyol pathway resulting in the excessive generation of reactive
xygen species (ROS) (Sivitz and Yorek, 2010; Jang et al., 2010). ROS
n concert with nitric oxide species (NOS) alter intracellular macro-
olecules, such as lipids, proteins, nucleic acids and carbohydrate
s well as constituents of membranes (Halliwell and Gutteridge,
007). The level of lipid peroxidation in cell is controlled by enzy-
atic and nonenzymatic antioxidant system, scavenger systems,
hose levels are disturbed in diabetes. Thus, elevated ROS and
OS levels together with depleted endogenous antioxidant capac-
ty aggravate oxidative stress (Pérez-Matute et al., 2009).
Although scientists and clinicians largely focus on common dia-
etic complications such as diabetic cardiomyopathy, nephropathy,
europathy, retinopathy, and skin ulcer, diabetes has the detri-
ental effects on testis (Mallick et al., 2007; Zhao et al., 2010). It
s well known that infertility is common complication in diabetic
en and also in experimentally induced diabetes mellitus in rats,
ale reproductive activity are also suppressed. Diabetes is consid-
red to produce erectile dysfunction, retrograde ejaculation and
educed levels of testicular hormone and seminal quality changes
n diabetic men (Pitteloud et al., 2005). Serum testosterone impair-
ent and varying degrees of testicular and epididymal structural
esions have also been demonstrated in STZ-induced diabetic ani-
al models (Anderson and Thliveris, 1986; Cai et al., 2000). Besides,
ree radicals, which control sperm maturation, capacilitation and
yperactivation in health, can induce lipid peroxidation, DNA dam-
ge and apoptosis of spermatozoa when hyperglycaemia triggers a
ascade of biochemical event resulting in oxidative stress (Kothari
t al., 2010).
Both forms of diabetes are associated with long-term complica-
ions that affect function of reproductive organs. However, the vast
ajority of patients with type 1 diabetes are diagnosed before the
ge of 30 (Williams and Pickup, 2004), thus diabetes affects much
ore males prior to and during their reproductive years. On the
ther hand, the potential impact of diabetes in young males and
ts effects on their reproductive function remain poorly explored.
ue to multiple action of STZ intoxication (and keeping in mind the
rowing prevalence of diabetes mellitus in the world) understand-
ng how uncontrolled hyperglyceamia impacts the reproductive
unction and seeking for efficient drugs able to alleviate diabetes-
nduced complications, are yet important areas of inquiry. In this
ork, we focused our attention on C60 fullerene, the third allotrope
f carbon, which is considered to be the most prominent member
f the nanomaterial family (Kroto et al., 1985). Since their discov-
ry in 1985, fullerenes have been investigated extensively due to
heir unique physicochemical properties and biological activities
Prato, 1997; Bosi et al., 2003; Satoh and Takayanag, 2006). C60
s practically insoluble in water that limits its biomedical applica-
ion (Ruoff et al., 1993). Various methods of chemical derivatization
nd supramolecular complexes formation have been developed to
ake fullerene molecules water-soluble and increase their easef use in biological systems (Nakamura and Isobe, 2003; Partha
nd Conyers, 2009). However, it is important to emphasize that C60
anoparticles prepared by different solubilisation and modification
ethods exhibit highly distinct biological effects. Some function-
lized derivates of fullerenes are reported to display pronounced82 (2011) 69–81
toxic effects in vivo and in vitro indicating that biological responses
highly depends on the chemical nature of attached functional
groups but not C60 core itself (Kolosnjaj et al., 2007). Neverthe-
less, fullerenes appeared to be the potent antioxidants and being
investigated as therapies for a wide range of diseases (Beuerle et al.,
2008). C60 fullerene and some of its derivatives have been shown
to exhibit effective protection against oxidative stress in vitro and
in vivo (Tsai et al., 1997; Monti et al., 2000; Srdjenovic et al., 2010)
without inducing acute or subacute toxicity (Gharbi et al., 2005;
Mori et al., 2006). However, despite the growing body of effects
noted in the literature, question remains regarding fullerene effects
on mammal’s reproductive function.
In contrary to the methods of chemical modifications of
fullerene, the method for producing of water-soluble chemically
unmodified C60 fullerene without using of any solubilizers or stabi-
lizers has been developed (Andrievsky et al., 1995). The preparation
obtained has been denoted as “hydrated C60 fullerene” (C60HyFn).
Stable aqueous solutions of C60HyFn in water (C60 fullerene water
solution – C60FWS) contain single hydrated C60 fullerene molecules
as well as their labile clusters (secondary associates) with the
size of 3–36 nm. Chemically, C60HyFn is highly hydrophilic and
highly stable donor–acceptor complexes C60 with water molecules
– C60@{H2O}n, n = 22–24 (Andrievsky et al., 1995, 1999, 2002;
Avdeev et al., 2004). Biological effects of C60HyFn have been the
subjects of intense research over the past decade, indicating its
beneficial action as neuroprotectant, anticancer, antiinflammatory,
antiatherogenic, and radioprotective agent (Andrievsky et al., 2005,
2009; Podolski et al., 2007; Tykhomyrov et al., 2008). It is proved
that positive effects of C60HyFn are mainly determined by its unique
bio-antioxidative properties, which are unexpectedly manifested
even at super-small concentrations and doses (Andrievsky et al.,
2005, 2009, 2010).
Using of co-administration of toxin STZ, which is able to induce
systemic metabolic disturbance in the whole organism and dia-
betic complications as well, and nanostructures of hydrated C60
fullerene, which are known to be the potent antioxidant and tissue-
protective agent, we were focused on two general questions: (1)
what are the effects of C60HyFn on reproductive function of male
rats, if any; (2) whether C60HyFn administered to STZ-treated rats
is capable of preventing of testicular damage and increasing sperm
viability and quality? The answer on the second question could pro-
vide clinical implication of water-soluble fullerenes for developing
novel antisterility drugs.
2. Materials and methods
2.1. Chemicals and C60 fullerene water solution (C60FWS)
C60 fullerene samples with purity of more than 99.98% were obtained from
“TERM” (Moscow State University, Russia). Sodium lauryl sulfate (SDS), acetic
acid, thiobarbituric acid aqueous solution (TBA), n-butanol, pyridine, 1,1,3,3-
tetramethoxypropane standard, trichloroacetic acid (TCA), phosphate buffer,
5,5-dithiobis(2-nitrobenzoic acid) (DTNB), and reduced glutathione (GSH) standard,
reagents, were obtained from Fluka (Taufkirchen, Germany). All the other chemi-
cals were purchased from Sigma–Aldrich Chemical Co. (St. Louis, MO, USA). All the
chemicals used were of analytical grade.
C60FWS was produced without using any solubilizers and chemical modification.
This method is based on transferring of fullerene from organic solution into the aque-
ous phase by ultrasonic treatment as described elsewhere (Andrievsky et al., 2005).
Concentrated C60FWS (up to 5.5 × 10−3 M ∼ 4 mg/ml) contains both single C60HyFn
(C60@{H2O}n or C60@nH2O, where n = 22–24) and their labile nanoassociates with
the size of 3–72 nm (Andrievsky et al., 1999, 2002; Avdeev et al., 2004). Concen-
trated C60FWS solution was diluted in distilled water so that the final concentration
of C60HyFn in drinking water was 30 nM (Tykhomyrov et al., 2008).2.2. Animals and experimental design
The experimental protocols were approved by the local Animal Use Commit-
tees of Firat University (Elazig, Turkey). Animal care and experimental protocols
complied with the NIH Guide for the Care and Use of Laboratory Animals (NIH pub-
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–9 weeks and weight in the range of 180–210 g, were obtained and maintained
rom Firat University Experimental Research Centre (Elazig, Turkey). The animals
ere housed in polycarbonate cages in a room with a 12 h day–night cycle, tem-
erature of 24 ± 3 ◦C, humidity of 45–65%. During the whole experimental period,
nimals were fed with a balanced commercial diet (Elazig Food Company, Elazig,
urkey) ad libitum and fresh distilled drinking water (with or without fullerene)
as given ad libitum.
.3. Experimental design and induction of diabetes
The animals were randomly divided into 4 groups with 6 animals in each group
s in the following way:
(i) Control group: healthy rats received distilled water only;
(ii) C60HyFn group: healthy rats received distilled water containing aqueous solu-
tions of C60HyFn at concentration of 30 nM (∼22 ng/ml);
iii) STZ-diabetes group: STZ-induced diabetic rats received distilled water only;
iv) STZ-diabetes + C60HyFn group: STZ-induced diabetic rats received aqueous
solution of C60HyFn at a concentration of 12 nM (∼9 ng/ml).
Diabetes in overnight fasted rats of STZ-diabetes and STZ-diabetes + C60HyFn
roups was induced by a single intraperitoneal injection of a buffered solution (0.1 M
itrate, pH 4.5) of STZ at a dose of 50 mg/kg body weight (Baydas et al., 2003). The
lood glucose level was measured using reagent strips (Contour, Bayer, Leverkusen,
ermany). The animals were considered diabetic if blood glucose values were more
han 300 mg/dl at 72 h after STZ treatment, using a drop of blood obtained by a tail-
ein puncture monitored at different time intervals throughout the study. Twenty
ats were made diabetic in this way.
It should be noted that the daily consumption of C60HyFn by the animals in
oth C60HyFn and STZ-diabetes + C60HyFngroups were equal to ∼4 g/kg. The ani-
als in C60HyFn group drank water containing C60HyFn at a concentration of 30 nM
∼22 ng/ml). Whereas, the rats in STZ-diabetes + C60HyFn group drank water con-
aining C60HyFn at concentration of 12 nM (9 ng/ml), since the rats in this group
rank approximately 2.5 times more water compared to C60HyFn group animal.
herefore, the rats in STZ-diabetes + C60HyFngroup drank water containing 2.5 times
ess concentration of C60HyFn so that these animals of STZ-diabetes + C60HyFngroup
eceived equal amount of C60HyFn to the rats in C60HyFn group, as 4 g/kg daily.
he food and water intake were monitored daily throughout the study period (5
eeks).
.4. Sample collection and homogenate preparation
After the animals were decapitated at the end of the 5th week, the blood was col-
ected and testis, epididymides, seminal vesicles and ventral prostate were removed,
leared of adhering connective tissue and weighed. Right testicles were fixed with
ouin’s fluid. Left testicles were frozen in liquid nitrogen and stored at −70 ◦C until
se for malondialdehyde (MDA), GSH, fatty acids and alpha-tocopherol analysis.
erum was separated and also stored at −70 ◦C until use to estimate some biochem-
cal parameters using the appropriate kits (Boehringer Mannheim, Germany).
.5. Histopathology
After fixation in Bouin’s solution, the tissues were embedded in paraffin for
UNEL histochemistry and haematoxylin and eosin staining. All assessment was
erformed in a blinded fashion. For histological examination, sections were stained
ith haematoxylin and eosin. Using light microscopy, diameters of seminiferous
ubules and germinal cell layer thicknesses were measured and the damages in
esticular tissue were evaluated. The images were viewed and analyzed by using a
omputer-assisted image analyzer system consisting of a microscope (Olympus BX-
1, Tokyo, Japan), and the images were transferred into the computer using a digital
ideo camera (JVC TK-890E, Japan). For each animal thirty tubules were evaluated.
ohnsen’s testicular score system (Johnsen, 1970) was used for evaluation of degrees
f the histopathological changes in control and treatment groups. All cross sectioned
ubules were evaluated systematically, and a score between 1 (very poor) and 10
excellent) was given to each tubule according to Johnsen’s criteria.
.6. Localization of apoptotic cells in the testis
The localization of apoptotic cell death in the spermatogenic cells was defined
y terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)
ssay with theApopTag Peroxidase In Situ Apoptosis Detection Kit (Chemicon,
emecula, CA). Briefly, the fixed testicular tissue was embedded in paraffin, and
ectioned at 4 m. The paraffin sections were deparaffinized in xylene, dehydrated
hrough graded alcohol, and washed in PBS. The sections were treated with 0.05%
roteinase K for 5 min, which was followed by treatment with 3% hydrogen peroxide
or 5 min to inhibit endogenous peroxidase. After washing in PBS, sections were then
ncubated with the TUNEL reaction mixture containing terminal deoxynucleotidyl
ransferase (TdT) enzyme and digoxigenin-11-dUTP at 37 ◦C for 1 h in humidified
hamber at 37 ◦C for 1 h, and then stop/wash buffer was applied for 30 min at 37 ◦C.82 (2011) 69–81 71
Sections were visualized with diaminobenzidine (DAB) substrate. Negative con-
trols were performed using distilled water in the place of the TdT enzyme. Sections
were counterstained with Mayor’s hematoxylin, dehydrated in graded alcohol, and
cleared.
2.7. Sperm analyses
2.7.1. Epididymal sperm concentration
The epididymal sperm concentration was determined with a hemocytometer
using a modified method (Türk et al., 2008). The right epididymis was finely minced
by anatomical scissors within 1 ml of isotonic saline in a Petri dish. It was completely
squashed by a tweezers for 2 min, and then allowed to incubate at room temperature
for 4 h to provide the migration of all spermatozoa from epididymal tissue to fluid.
After incubation, the epididymal tissue–fluid mixture was filtered via strainer to
separate the supernatant from tissue particles. The supernatant fluid containing
all epididymal spermatozoa was drawn into the capillary tube up to 0.5 lines of
the pipette designed for counting red blood cells. The solution containing 0.595 M
sodium bicarbonate, 1% formalin and 0.025% eosin was pulled into the bulb up to 101
lines of the pipette. This gave a dilution rate of 1:200 in this solution. Approximately
10 l of the diluted sperm suspension was transferred to both counting chamber of
Improved Neubauer (Deep 1/10 mm, LABART, Darmstadt, Germany) and allowed to
stand for 5 min. The spermatozoa in both chambers were counted with the help of
light microscope at 200× magnification.
2.8. Sperm motility
Freshly isolated left epididymal tissue was used for the analysis of sperm motil-
ity. The percentage sperm motility was evaluated using a light microscope with
heated stage. For this process, a slide was placed on a light microscope with a
heated stage warmed up to 37 ◦C, and then several droplets of Tris–buffer solu-
tion [0.3 M Tris (hydroxymethyl) aminomethane, 0.027 M glucose, 0.1 M citric acid]
were dropped on the slide and a very small droplet of fluid obtained from left cauda
epididymis with a pipette was added to the Tris–buffer solution and mixed by a
cover-slip. The percentage of sperm motility was evaluated visually at 400× magni-
fication. Motility estimates were performed from 3 different fields in each sample.
The mean of the 3 successive estimations was used as the final motility score.
2.9. Sperm morphology
To determine the percentage of morphologically abnormal spermatozoa, the
slides stained with eosin–nigrosin (1.67% eosin, 10% nigrosin and 0.1 M sodium cit-
rate) were prepared. The slides were then viewed under a light microscope at 400×
magnification. A total of 300 spermatozoa were examined on each slide (3000 cells
in each group), and the head, tail and total abnormality rates of spermatozoa were
expressed as percentage (Türk et al., 2008).
2.10. Determination of MDA–TBA level
The concentration of TBARS in the tissues samples was estimated by the method
of Niehaus and Smuelson (1968). In brief, 1 ml of tissue homogenate (supernatant;
Tris–HCl buffer, pH 7.5) was mixed with 2 ml of (1:1:1 ratio) TBA–TCA–HCl reagent
(0.37% thiobarbituric acid, 0.25 N HCl, and 15% TCA) placed in water bath for
60 min, cooled, and centrifuged at room temperature for 10 min. Thiobarbituric acid-
reactive substances (TBARS) were determined by reading the fluorescence detector
set at  (excitation) = 515 nm and  (emission) = 543 nm. TBARS calculated from a
calibration curve using 1,1,3,3-tetraethoxypropane as the standard. The MDA–TBA
complex was analyzed using the HPLC equipment. The equipment consisted of
a pump (LC-10 ADVP), a Fluorescence detector (RF–10XL), a column oven (CTO-
10ASVP), an autosampler (SIL-10ADVP) a degasser unit (DGU-14A) and a computer
system with class VP software (Shimadzu, Kyoto, Japan). Inertsil ODS-3 column
(15 mm × 4.6 mm, 5 m) was used as the HPLC column. The column was eluted
isocratically at 20 ◦C with a 5 mM sodium phosphate buffer (pH 7.0) and acetoni-
trile (85:15, v/v) at a rate of 1 ml/min (de las Heras et al., 2003). The values were
expressed as mM/g tissues.
2.11. Determination of GSH level in tissue samples
Reduced glutathione (GSH) was determined by the method of Ellman (1959).
Briefly 1 ml of tissue homogenate was treated with 1 ml of 5 metaphosphoric acid
(Sigma, St. Louis, MO), the mixtures were centrifuged in 5000 rpm and the super-
natants were taken. After deproteinization, the supernatants were allowed to react
with 1 ml of Ellman’s reagent (30 mM 5,5′-dithiobisnitro benzoic acid in 100 ml of
0.1% sodium citrate). The absorbance of the yellow product was read at 412 nm in
spectrophotometer. Pure GSH was used as standard for establishing the calibration
curve (Akerboom and Sies, 1981).
2.12. Lipid extraction
Lipids of tissue samples were extracted with hexane–isopropanol (3:2, v/v) by
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exane–isopropanol mixture. Fatty acids in the lipid extracts were converted into
ethyl esters including 2% sulphuric acid (v/v) in methanol (Christie, 1992). The
atty acid methyl esters were extracted with 5 ml n-hexane. Analysis of fatty acid
ethyl ester was performed in a Shimadzu GC-17A instrument gas chromatograph
quipped with a flame ionization detector (FID) and a 25 m, 0.25 mm i.d. Permabond
used-silica capillary column (Machery – Nagel, Germany). The oven temperature
as programmed between 145 and 215 ◦C, 4 ◦C/min. Injector and FID temperatures
ere 240 and 280 ◦C, respectively. The nitrogen carrier gas flow was 1 ml/min. The
ethyl esters of fatty acids were identified by comparison with authentic external
tandard mixtures analyzed under the same conditions. Class GC 10 software version
.01 was used to process the data. The results were expressed as g/g tissue.
.13. Saponification and extraction
Alpha-tocopherol, alpha-tocopherol acetate and cholesterol were extracted
rom the lipid extracts by the method elaborated by Sánchez-Machado et al. (2004),
ith minor modifications. 5 ml of n-hexane/isopropyl alcohol mixture treated with
ml of KOH solution (0.5 M in methanol) were added and immediately vortexed
or 20 s. The tubes were placed in a water bath at 80 ◦C for 15 min. Then after cool-
ng in iced water, 1 ml of distilled water and 5 ml of hexane was added, and the
ixture was rapidly vortexed for 1 min, then centrifuged for 5 min at 5000 rpm.
he supernatant phase were transferred to another test tube and dried under nitro-
en. The residue was redissolved in 1 ml of the HPLC mobile phase (68:28:4 (v/v/v)
ethanol:acetonitrile:water). Finally, an aliquot of 20 l was injected into the HPLC
olumn. Before injection, the extracts were maintained at −20 ◦C away from light.
.14. Chromatographic conditions
Chromatographic analysis was performed using an analytical scale
15 cm × 0.45 cm i.d.) Supelco LC 18 DB column with a particle size 5 m
Sigma, USA). HPLC conditions were as follows: mobile phase 60:38:2 (v/v/v):
cetonitrile:methanol:water; a flow rate of 1 ml/min; column temperature 30 ◦C.
he detection was operated using two channels of a diode-array spectropho-
ometer, and 202 nm for alpha-tocopherol and cholesterol. Alpha-tocopherol,
lpha-tocopherol acetate and cholesterol were identified by retention and spectral
ata (Sánchez-Machado et al., 2002; Lopez-Cervantes et al., 2006).
.15. Serum testosterone
The plasma testosterone level was measured by ELISA method using DRG Elisa
estosterone kit (ELISA EIA-1559, 96 Wells kit, DRG Instruments, GmbH, Marburg,
ermany) according to the standard protocol supplied by the kit manufacturer.
.16. Statistical analysis
One-way analysis of variance (ANOVA) and post hoc Tukey–HSD test were used
o determine differences between groups in all parameters except serum testos-
erone level, whose statistical comparison was performed using the nonparametric
ann–Whitney U test. Results are presented as means ± S.E.M. Values were con-
idered statistically significant if p < 0.05. The SPSS/PC program (Version 10.0; SPSS,
hicago, IL) was used for the statistical analysis.
. Results
.1. Reproductive organ weights
Absolute and relative organ weights of testis, epididymis, right
auda epididymis, seminal vesicules and prostate of all groups at
he end of the study period are shown in Fig. 1 as bar graph. The
elative organ weights were estimated by dividing the absolute
eproductive organ weights to body weight. C60HyFn administra-
ion to healthy animals had no significant effects on weights of
able 1
perm parameters of control and different treatment groups (mean ± SEM).
Groups Parameters
Sperm motility (%) Epididymal sperm concentra
(million/cauda epididymis)
Control 76.7 ± 4.0a 99.8 ± 8.6a
C60HyFn 83.3 ± 2.7a 103.2 ± 9.6a
STZ 30.6 ± 3.7b 42.5 ± 9.1b
STZ+C60HyFn 57.8 ± 2.4c 93.8 ± 13.2a
he mean differences between the values bearing different superscript letters within the82 (2011) 69–81
the reproductive organs in comparison to the control group. How-
ever, in STZ-diabetes group, absolute weights of testis, epididymis,
right cauda epididymis, seminal vesicules and prostate and relative
weights of right cauda epididymis, seminal vesicules and prostate
were significantly less than those of control group (p < 0.001).
Although absolute weights of testis and epididymis were signifi-
cantly decreased in diabetic rats compared to control and C60HyFn
administration caused the weight of epididymis to increase sig-
nificantly when compared to STZ-diabetes group (p < 0.001), there
were no significant differences between the groups in their relative
weights. Hence, the weights of testis and epididymis are correlated
to whole body weight. Administration of C60HyFn to STZ-induced
diabetes mellitus animals resulted in statistically significant incre-
ments in absolute weights of epididymis and seminal vesicules and
relative weight of seminal vesicules (p < 0.001).
3.2. Epididymal sperm characteristics
Epididymal sperm characteristics of control, C60HyFn, diabetic
and C60HyFn administered diabetic rats are presented in Table 1.
There was no significant difference in sperm motility, epididymal
sperm concentration and abnormal sperm rate between con-
trol and C60HyFn groups, while there is a numerical increase
in sperm motility and epididymal sperm concentration and a
decrease in the rate of abnormal sperm rate in C60HyFn group.
In STZ-induced diabetic rats, there was a significantly less sperm
motility and epididymal sperm concentration and higher rate of
tail and head abnormality of sperm than those in control animals
(p < 0.001). Administration of C60HyFn to diabetic rats attenuated
hyperglycaemia-induced effects on the sperm characteristics. The
increase in sperm motility, epididymal sperm concentration and
the decrease in abnormal sperm rate were statistically signifi-
cant (p < 0.001). Furthermore, there was no significant difference
in epididymal sperm concentration between control, C60HyFn and
STZ-diabetes + C60HyFn groups.
3.3. Testicular histopathology
Histological sections from testis of control, C60HyFn, STZ-
diabetes and STZ-diabetes + C60HyFn groups are presented in Fig. 2.
Histological appearances of testicular tissues of control (Fig. 2A) and
C60HyFn groups (Fig. 2B) were similarly normal. Marked changes
including degeneration, desquamation, disorganisation and reduc-
tion in germinal cells, interstitial oedema and congestion were
evident in the testis of diabetic rats (Table 2, Fig. 2C). Adminis-
tration of C60HyFn to diabetic rats caused a marked amelioration
in testicular histological view, reducing the given histopathological
changes induced by diabetes mellitus except germinal disorgani-
sation, interstitial oedema and congestion (Table 2, Fig. 2D). The
diameter of seminiferous tubule, thickness of germinal cell layer
and Johnsen’s criteria for control, C60HyFn, STZ-diabetes and STZ-
diabetes + C60HyFn groups are shown in Table 3. It was found that
the diameter of seminiferous tubule and Johnsen’s criteria were
significantly decreased in STZ-diabetes group compared with the
tion Abnormal sperm rate (%)
Head Tail Total
3.2 ± 1.1a,c 2.5 ± 0.5a 5.7 ± 1.0a
1.8 ± 0.6a 3.0 ± 0.4a 4.8 ± 0.9a
18.2 ± 4.1b 12.4 ± 1.5b 30.6 ± 3.2b
7.3 ± 0.8c 7.0 ± 0.7c 14.3 ± 1.2c
same column are statistically significant (p < 0.001).











ig. 1. Absolute (A) and relative (B) weights of reproductive organs including testis
ean differences between the values bearing different letters for the same organs aontrol and C60HyFn (p < 0.001) groups. However, these values
ere significantly increased in the C60HyFn-treated diabetic rats
ompared with the diabetic rats (p < 0.001). Though not significant
similar pattern was observed in the thickness of germinal cell
ayer.
able 2
he existence of some pathological lesions in rat testicular tissues of control and differen
he following: 0 – normal; 1 – mild; 2 – moderate; 3 – severe.
Control
Degeneration in Sertoli cells 0
Degeneration in germinal cells 0
Disorganisation in germinal cells 0.1
Interstitial oedema and capillary congestion 0.1dymis, right cauda epididymis, vesicular seminalis and prostate (mean ± SEM). The
tistically significant (p < 0.001).
3.4. Evaluation of TUNEL stainingApoptosis in testis of control, C60HyFn, STZ-diabetes and STZ-
diabetes + C60HyFn groups of rats, demonstrated by TUNEL staining,
are shown in Fig. 3. In the current study, TUNEL-positive cells had
t experimental groups. Severety of the changes was scored between 0 and 3 as in
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roup. (B) Normal histological appearance of seminiferous tubules in C60HyFn gro
n STZ-diabetes group. (D) Histological appearance of seminiferous tubules. Note t
alibration bar: 50 m.
he typical morphological features of apoptosis, including chro-
atin condensation, cytoplasmic budding and apoptotic bodies.
UNEL-positive cells were occasionally observed in the testis of
ontrol and C60HyFn-administered rats (Fig. 3A and B). Whereas
he number of positive cells were significantly increased in the
estis of diabetic rats (p < 0.001) (Fig. 3C). TUNEL-positive cells were
etected in spermatogenetic cells. However, a significant decrease
n the number of TUNEL-positive cells was observed in the testis of
ydrated C60 fullerene-treated diabetic rats (Fig. 3D) with respect
o the STZ-diabetes group (p < 0.001).
In order to estimate the apoptotic index, TUNEL-positive cells in
eminiferous tubules (100 per animal) in 20 randomly chosen fields
ere counted. The apoptotic index was calculated as the percentage
f cells with TUNEL positivity. In the apoptotic index, a significant
ncrease was striking in the STZ-diabetes group (11.4 ± 2.7%) when
ompared to that of control (0.5 ± 0.2%) and C60HyFn (0.6 ± 0.3%)
roups. C60HyFn-treated diabetic rats exhibited significantly lower
poptotic index (1.1 ± 0.4%).
able 3
iameter of seminiferous tubules, germinal cell layer thickness and Johnsen’s testicular s
Groups Diameter of seminiferous tubules (m)
Control 261.8 ± 2.02a,*
C60HyFn 258.2 ± 3.00a,**
STZ 246.6 ± 3.01b
STZ + C60HyFn 256.4 ± 2.24a,***
he mean differences between the values bearing different superscript letters within the
* p < 0.001.
** p < 0.01 compared with STZ-diabetes group;
*** p < 0.05 compared with STZ-diabetes group;
† p < 0.001 compared with STZ-diabetes group.) Disorganisation, degeneration and interstitial oedema and capillary congestion
elioration in histopathological changes observed in STZ-diabetes + C60HyFn group.
3.5. Biochemical parameters
In terms of toxicity assessment of C60HyFn, serum level of lactate
dehydrogenase (LDH), aspartate aminotransferase (AST), alanine
aminotransferase (ALT), alkaline phosphatase, creatinine kinase,
total bilirubin, direct bilirubin, indirect bilirubin, total protein, albu-
min, urea, creatinine and uric acid and concentrations of sodium,
chloride and inorganic phosphate ions were also measured (data
not shown). No significant difference in any of these biochemi-
cal parameters tested was observed after the administration of
C60HyFn for 35 days between groups.
Levels of glucose and testosterone in serum, levels of lipid
peroxidation (TBARS) and antioxidant (GSH), some fatty acids
(palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid,
arachidonic acid and docosapentaenoic acid), cholesterol, alpha-
tocopherol and alpha-tocopherol acetate in testicular tissue are
presented in Table 4. Induction of diabetes by STZ resulted in a
significant elevation in plasma glucose in comparison to control
core.
Germinal cell layer thickness (m) Johnsen’s testicular score
73.46 ± 1.12a 9.9 ± 0.1a,†
72.26 ± 1.34a 9.8 ± 0.1a,†
68.93 ± 1.38a 7.6 ± 0.2b
71.17 ± 2.24a 9.1 ± 0.2a,†
same column are statistically significant.


















ig. 3. Representative photomicrographs of TUNEL-stainings in the testes of contro
taining control is also illustrated to ensure the staining methods are working well
UNEL-stained cells im breast tissue where continous apoptosis takes place. Arrow
nd C60HyFn groups (p < 0.001) and administration of C60HyFn to
he diabetic animals did not make any significant change in blood
lucose level (Table 4).
In diabetic rats, levels of alpha-tocopherol and alpha-tocopherol
cetate were significantly reduced (p < 0.001). However, treating
iabetic rats with C60HyFn resulted in significant corrective effects
n these parameters towards the control levels (p < 0.001).
While administration of C60HyFn to nondiabetic rats did not
ignificantly change the LPO measured as TBARS levels, a signif-
cant increase in LPO measured was evident in testis of diabetic
ats (Table 4). C60HyFn administrations to diabetic rats provided
umerical but not statistically significant decrease in LPO level as
ompared to STZ-diabetes group. Testicular tissue GSH level was
ignificantly lower in the diabetic rats than that in the control
p < 0.001). Although administration of C60HyFn did not increase
SH level when compared to the control group, C60HyFn adminis-C60HyFn (B), STZ-diabetes (C) and STZ-diabetes + C60HyFn (D) groups. (E) Negative
that there were no detectable signals in the negative control. (F) Positive control:
ate candidate apoptotic cells. Calibration bar: 50 m.
tration to diabetic rats provided a statistically significant increase
in GSH level as compared to diabetic group (p < 0.05).
In STZ-induced diabetic rats, levels of palmitic acid, palmitoleic
acid, oleic acid and linoleic acid were significantly decreased when
compared to control group (p < 0.001) (Table 4). C60HyFn treatment
of diabetic animals increased palmitic acid (p < 0.001), palmitoleic
acid (p < 0.001), stearic acid (p < 0.05), arachidonic acid and docos-
apentaenoic acid significantly. No significant differences in stearic
acid (18:0) were found between any of these groups.
In streptozotocin-induced diabetic rats, cholesterol level was
significantly decreased when compared with controls, but C60HyFn
treatment resulted in a significant elevation of cholesterol level
(p < 0.001) so that there was no significant difference between con-
trol and STZ-diabetes + C60HyFn groups.
There was no significant difference in serum testosterone level
between control and C60HyFn groups. Serum levels of testosterone
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Table 4
Levels of serum glucose and testosterone and testicular tissue thiobarbituric acid reactive substances (TBARS), glutathione (GSH), cholesterole, -tocopherol, -tocopherol
acetate and some fatty acids including palmitic, palmitoleic, stearic, oleic, linoleic, arachidonic and docosapentaenoic acids (mean ± SEM).
Compound Control (n = 6) C60HyFn (n = 6) STZ (n = 6) STZ + C60HyFn (n = 6)
Glucose (mg/dl) 118.5 ± 3.4a 113.4 ± 3.9a 481.5 ± 18.0b,# 418.0 ± 41.1b,#
TBARS (nmol/ml) 74.9 ± 3.1a 56.6 ± 5.9a 192.8 ± 21.5b,# 170.9 ± 5.3b,#
GSH (nmol/ml) 57.9 ± 1.4a 49.2 ± 2.4a,b 46.1 ± 2.4b,• 54.5 ± 3.2a,†
-Tocopherol (g/g) 28.6 ± 0.9a,d 31.8 ± 2.4a,b 13.6 ± 0.7c,# 25.2 ± 1.7d
-Tocopherol acetate (g/g) 5.26 ± 0.27a 7.04 ± 0.49b 2.08 ± 0.21c,# 2.69 ± 0.09c,#
Cholesterole (mM/g) 1.70 ± 0.06a 1.70 ± 0.08a 1.33 ± 0.03b,# 1.58 ± 0.08a,†
Testosterone (ng/dl) 102.9 ± 13.3a 107.7 ± 11.9b 29.0 ± 3.6c,# 44.0 ± 4.6d,#,†
Palmitic acid (16:0) (g/g) 990.0 ± 32.6a,+ 797.3 ± 23.2b,+ 551.7 ± 19.1c,+ 677.5 ± 31.6d,+
Palmitoleic acid (16:1) (g/g) 237.0 ± 32.6a,+ 101.9 ± 8.3b,+ 35.6 ± 7.5c,+ 141.7 ± 2.9d,+
Stearic acid (18:0) (g/g) 221.5 ± 7.8a,b 212.0 ± 13.6a,b 180.9 ± 9.4a 243.9 ± 13.9b,†
Oleic Acid (18:1) (g/g) 761.0 ± 30.8a 392.0 ± 33.0b 186.9 ± 22.7c,# 217.8 ± 13.7c,#
Linoleic acid (18:2 n6) (g/g) 999.5 ± 33.0a 476.3 ± 30.9b,* ,† 155.1 ± 6.1c,* 158.6 ± 14.6b,c
Arachidonic acid (20:4 n6) (g/g) 341.8 ± 13.9a 465.6 ± 31.8b,* 348.9 ± 14.9a,b 468.8 ± 18.1c,#
Docosapentaenoic acid (22:5 n6) (g/g) 249.1 ± 6.0a 330.6 ± 14.1b,c,* 289.5 ± 11.9a,b 366.1 ± 13.7c, ,•
The mean differences between the values bearing different superscript letters within the same line are statistically significant (p < 0.05).
* p < 0.01 vs. control.


































# p < 0.001 vs. control and C60HyFn group.
+ p < 0.001 compared with other groups.
 p < 0.001 compared with STZ-diabetes group.
• p < 0.001 compared with control.
n STZ-diabetes group were significantly lower than that in the con-
rol group (p < 0.001) (Table 4). Administration of C60HyFn to the
iabetic rats resulted in a slight but significant corrective effect on
he testosterone level towards the control (p < 0.05).
. Discussion
In the present study, we have elaborated the protective effects
f C60HyFn against STZ-diabetes-induced damages of the repro-
uctive functions of male rats, evaluating histological changes,
poptosis identified by TUNEL staining in testicular tissue and
evels of serum testosterone and testicular MDA, GSH, alpha-
ocopherol and alpha-tocopherol acetate and some fatty acids. Our
esults confirmed that STZ-induced diabetes mellitus caused tes-
icular dysfunctions in male rats as reported by others (Hakim and
oldstein, 1996) and for the first time showed that administration
f C60HyFn to diabetic rats attenuated the testicular dysfunction
nd spermatogenic disruption in the testis induced by uncontrolled
yperglyceamia in male rats.
.1. Effects of C60HyFn in nondiabetic animals
The treatment with C60HyFn did not result in an acute or
ub-acute toxicity in testis as evidenced histologically and bio-
hemically. No tissue necrosis, fibrosis, and other degenerative
igns were observed and no significant differences were observed
n serum level of LDH, AST, ALT, alkaline phosphatase, creatinine
inase, total bilirubin, direct bilirubin, indirect bilirubin, total pro-
ein, albumin, urea, creatinine and uric acid and concentrations of
odium, chloride and inorganic phosphate ions at the given concen-
ration (data not shown). Our findings on non-toxicity of pristine
60 are consistent with those of previous studies (Gharbi et al.,
005; Mori et al., 2006; Tykhomyrov et al., 2008).
.2. Reproductive organ weights
There are some studies reporting that the relative weights of
pididymis, seminal vesicle and prostate were reduced in STZ-
reated rats (Scarano et al., 2006; Shrilatha and Muralidhara, 2007;
avarro-Casado et al., 2010), which are in agreement with our data
btained in the present study. The significant reductions in the
eights of right cauda epididymis, seminal vesicles and prostatein diabetic rats (Fig. 1) are likely to be due to low serum testos-
terone level, since testosterone is the major regulator of normal
growth of these organs (Mallick et al., 2007). The decreased testos-
terone level has been associated with absence or diminution of
serum insulin levels, since it has been shown that insulin ther-
apy restores body weight and the weight of most reproductive
organs (Seethalakshmi et al., 1987). The relative weight of the
testis increased in the STZ-treated group in the current study, it
is not significant though. This finding is consistent with the reports
by Scarano et al. (2006) and Shrilatha and Muralidhara (2007).
Navarro-Casado et al. (2010) demonstrated a decrease in testic-
ular weight after 6 weeks of diabetes inducted, which was but not
evident over time. After administration of C60HyFn to diabetic rats,
the weights of these reproductive organs were recovered towards
the control level.
4.3. Testicular histopathology
In our study, diabetes-induced changes in testis consisted of
decreased seminiferous tubular diameter (STD), degeneration in
germinal cells, disorganisation in germinal cells, interstitial oedema
and capillary congestion. In the present study, Johnsen’s scores
of diabetic rats were about 8/9, which indicates the presence of
mild testicular damage (Johnsen, 1970). Consistently, earlier work-
ers have demonstrated similar alterations in the morphology of
the testis (Cameron et al., 1985; Seethalakshmi et al., 1987). The
reduction in tubular diameter has also been demonstrated by some
other researchers (Anderson and Thliveris, 1986). Whereas Scarano
et al. (2006) did not find any alterations in the testicular structure,
which is likely to be that they used very short duration of diabetic
conditions before terminating the experiments.
Testicular tissue damage can primarily be accounted for by
decreased glucose utilization due to lack of insulin in STZ-induced
diabetic rat (Mallick et al., 2007). The decreased seminiferous
tubular diameter (STD) in diabetic rats may be due to low
gonadotrophins (Ballester et al., 2004) and testosterone (Castro
et al., 2002). Ballester et al. (2004) explained the decreased sem-
iniferous tubular diameter in diabetes by the decreased level of
FSH, which in turn, will diminish the response of the epithe-
lium of seminiferous tubules to FSH stimulation. Because of
insulin insufficiency insulin-mediated cell proliferation decreases
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f spermatogonia in seminiferous tubules and thus leading to a
ecrease in seminiferous tubule diameter. Seminiferous diame-
er has also been reported to be reduced in STZ-induced diabetes
ellitus (Guneli et al., 2008). However, administration of C60HyFn
o the diabetic rats ameliorated these histopathological deficits
y providing protection against the impairment of seminiferous
ubules. Johnsen’s scores of diabetic rats treated with C60HyFn were
early10, as good as control group.
.4. Epididymal sperm characteristics
Our observation on the lower epididymal sperm concentra-
ion and sperm motility and a higher abnormal sperm rate are
onsistent with those of previously reported studies on the male
eproductive disorders in diabetic state (Cai et al., 2000; Ghosh
t al., 2002). Scarano et al. (2006) have found higher rate of sperm
otility (73.3%) in the STZ-treated animals when compared to what
e have found in our study (30.6%). Yet, Navarro-Casado et al.
2010) found that sperm motility was uneffected by STZ intoxi-
ation. This can be accounted for by the difference in composition
f dilution medium used. The rate of the decrease in epididymal
perm concentration in the current study (∼40%) were comparable
o that reported by Shrilatha and Muralidhara (2007) (∼20%), but
esser than that reported by Scarano et al. (2006) (∼80%) and that
y Navarro-Casado et al. (2010) (∼70%). The decrease in epididy-
al sperm concentration can be explained by alterations in the
permatogenesis process (Scarano et al., 2006). Abnormal sperm
orphology observed in our study was also observed in the study
y Navarro-Casado et al. (2010). However, Scarano et al. (2006) did
ot find abnormal morphology in sperm morphology. This might
e due to that the duration of their study was too short (2–3 weeks)
or the abnormalities to develop.
Reduced epididymal sperm concentration and sperm motility
nd higher rate of abnormal sperm in diabetic rats could be inter-
reted as a combined effect of decreased Leydig cell function (as
videnced by reduced testosterone levels in serum/testis) (Tanaka
t al., 2001) and the oxidative stress induced by diabetes (Ghosh
t al., 2002). It is demonstrated that oxidative damaging effect of
ree radicals diminishes sperm motility and viability (Hsu et al.,
998). Shrilatha and Muralidhara (2007) reported that the sus-
eptibility of spermatozoa to oxidative stress in the epididymal
ilieu was increasingly evident after 2 weeks of STZ injection.
ummins et al. (1994) suggested that spermatozoa produced in the
estis are reasonably well protected by the microenvironment of
ertoli cells, but they are less protected against oxidation in the epi-
idymis, which apparently worsen the figure in epididymis where
perm is stored. It is reported that oxidative damage to sperm
an lead to DNA damage, altered membrane functions, impaired
otility, decreased fertilization capacity (Lopes et al., 1998). Alter-
atively, the marked decrease in epididymal sperm concentration
nd increase in the abnormal sperm rate in diabetic rats could
lso possibly be explained by the inhibition in spermatogenesis
Dawson et al., 1992).
In the current study, we demonstrated that administration of
60HyFn to diabetic rats resulted in marked recoveries in the epi-
idymal sperm concentration, sperm motility and rate of abnormal
perm rate towards the control levels. It might be interesting to note
hat administration of C60HyFn to non-diabetic animals resulted in
umerical but not statistically significant improvements in these
perm characteristics. Therefore, based on literature resources
Gharbi et al., 2005; Beuerle et al., 2008; Andrievsky et al., 2009;
rdjenovic et al., 2010), we state that C60HyFn treatment enhances
esticular antioxidant capacity and reduce oxidative stress and
hereby reduce diabetes-induced oxidative damage, leading to an
n improvement of epididymal sperm characteristic in nondiabetic
ats and restoration of epididymal sperm characteristic in dia-82 (2011) 69–81 77
betic rats. The protective effects of C60HyFn as an antioxidant on
the testis in the current study are consistent with similar earlier
findings in diabetic models (Dawson et al., 1992; Shrilatha and
Muralidhara, 2007). Consistently, as antioxidants, both ascorbic
acid and melatonin have been shown to prevent the loss of sperm
viability, membrane integrity and motility in vitro and to improve
the suppressed sperm quality in vivo (Dawson et al., 1992; Tan and
Reiter, 2005). Similarly Zhao et al. (2010) demonstrated the com-
plete prevention of diabetes-induced testicular oxidative damage
and apoptotic cell death by antioxidant n-acetyl cysteine (NAC).
4.5. TUNEL staining
The number of TUNEL-positive cells was significantly increased
in the germinal epithelium of diabetic testis (Fig. 3C), which indi-
cates that germinal cell apoptosis was induced by diabetes mellitus.
There are reports demonstrating increases in germ cell apoptosis in
the testis of STZ-induced diabetic animals (Cai et al., 2000; Shrilatha
and Muralidhara, 2007; Guneli et al., 2008). Increased apoptotic cell
death is reported to be implicated in the pathogenesis of testicular
dysfunction in diabetic males and results from increased status of
oxidative stress (Cai et al., 2000; Wang et al., 2003). The increased
oxidative stress in the testis of diabetic rats induces release of
cytochrome c and then activation of caspase, leading to apoptotic
cell death (Wang et al., 2003; Zhao et al., 2010).
We demonstrated that administration of C60HyFn in drink-
ing water after induction of diabetes by STZ significantly reduced
hyperglycaemia-induced apoptotic cell death in the testis. The pro-
tective properties of water-soluble fullerene derivatives against
apoptotic cellular death have been demonstrated in different mod-
els of diseases (Misirkic et al., 2009). The preventive effect of
C60HyFn on diabetes-induced apoptotic cell death is most likely
mediated by its antioxidant activity to suppress oxidative stress
and damage. Similarly Zhao et al. (2010) demonstrated complete
prevention of the diabetes-induced apoptotic cell death by of
antioxidant n-acetyl cysteine (NAC).
4.6. Biochemical parameters
After STZ injection, fasting blood glucose level was increased,
which are in line of early studies (Scarano et al., 2006). It is likely
that the testicular dysfunction and spermatogenic disruption may
partly be associated with the decreased testicular glucose utiliza-
tion due to the lack of insulin as suggested by Mallick et al. (2007).
4.7. MDA
Significant reduction in the levels of enzymatic and nonen-
zymatic antioxidants and an increase in ROS production are
well established features of the testicular tissues of diabetic ani-
mals, which are suggestive of the ongoing oxidative disturbances
(Pigeolet et al., 1990; Chandrashekar and Muralidhara, 2009;
Jelodar et al., 2009). There was a numerical but insignificant
decrease in MDA level in the testis of the rats treated with C60HyFn,
suggesting that hydrated C60 fullerene exerts a slight antiradical
activity even in the nondiabetic rats. Testicular tissue of diabetic
rats showed nearly three fold elevation in MDA levels indicating a
clear persistence of oxidative damage. Shrilatha and Muralidhara
(2007) reported roughly double increase in MDA level in testicular
tissue. MDA is an aldehyde resulting from peroxidation of plasma
membrane phospholipids, level of which is used as a marker of
lipid peroxidation extent. ROS can inactivate or alter the biologi-
cal activity of molecules including lipids and protein or DNA that
are essential for cell function. Increase in oxidative stress in the
testicular tissue is demonstrated to have profound effect on tes-
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007; Agarwal et al., 2008; Chandrashekar and Muralidhara, 2009).
lasma membrane of testicular cells including mature spermatozoa
ontain phospholipids composed of extremely high proportions of
olyunsaturated fatty acids (PUFAs), but their cytoplasm includes
elatively low concentrations of scavenging antioxidant enzymes
Yin et al., 1999; Valk and Hornstra, 2000; Gavazza and Catalá,
001). Therefore, this high concentration of PUFAs in cellular mem-
ranes makes it prone to lipid peroxidative degradation (Agarwal
t al., 2008). The structural and functional alterations may indi-
ate that oxidative stress is highly likely to contribute to the
evelopment of pathophysiological dysfunctions in the testis of
TZ-induced diabetic rats.
It is demonstrated that supplementation of C60HyFn helped to
educe MDA level. In early diabetic phase, STZ-induced oxidative
amage in testis is reported to be reversible by antioxidant sup-
lements (Shrilatha and Muralidhara, 2007). Authors showed that
scorbic acid offset the STZ-induced oxidative damage in testis
nd epididymal sperm as evident from diminished MDA and ROS
evels in cytosol and mitochondria and restoration of antioxidant
nzymes.
.8. Testicular antioxidants (GSH, vitamin E levels)
In the current study we determined a significant reduction
n GSH level in diabetic testis, which confirm previous studies
Pigeolet et al., 1990; Guneli et al., 2008; Jelodar et al., 2009; Zhao
t al., 2010). But the decrease in GSH in diabetic testis was much
ess than that reported by Shrilatha and Muralidhara (2007). How-
ver, the rats treated with C60HyFn restored the level of GSH to the
ontrol level.
In the current study, the decline in the levels of alpha-tocopherol
nd alpha-tocopherol acetate was a striking finding for diabetic
ats. The observed low level of alpha-tocopherol in the testis of
iabetic rats corroborate with similar earlier findings in diabetic
odels (Shrilatha and Muralidhara, 2007). Furthermore, a decrease
n the levels of alpha-tocopherol and alpha-tocopherol acetate in
esticular tissue of diabetic rats might also contribute to a decline
n GSH level or to the increased level of ROS in testis, because
lpha-tocopherol has antioxidant property (Fuller et al., 1996).
However, we observed a significant elevation of alpha-
ocopherol in diabetic and even in nondiabetic rats treated with
60HyFn. The elevation of alpha-tocopherol by C60HyFn might be
nother potential mechanism that C60HyFn exerts, restoring the
esticular dysfunction and spermatogenic disruption in the testis
nduced by diabetes mellitus in male rats, since alpha-tocopherol is
nown for its antioxidant, immune-enhancing, anti-inflammatory,
nd antiplatelet aggregation effects and is used clinically to pre-
ent complications of diabetes (Fuller et al., 1996). Specifically,
ocopherols are reported to detoxify lipid peroxyl radicals, as
ell as block the reactivity of singlet oxygen radicals (Kamal-
ldin and Appelqvist, 1996). It is interesting that alpha-tocopherol
ccumulates in the membranes of mitochondria and endoplasmic
eticulum within the cell where oxygen radical production is great-
st and thus where it is most required (Duthie et al., 1991). The
ntioxidant function of alpha-tocopherol is critical for the preven-
ion of oxidation of tissue PUFAs, reducing the susceptibility to lipid
eroxidation of tissue PUFAs (Fuller et al., 1996; Valk and Hornstra,
000). Polyunsaturated fatty acids are essential for the mainte-
ance of normal testicular function in rats. It is fair to state that
60HyFn up-regulated enzymatic and nonenzymatic antioxidants
uch as GSH and alpha-tocopherol.Cai et al. (2008) suggested that C60 fullerene displays not only
irect antioxidant properties towards free radicals, but also indirect
ntioxidant pathways, such as induction of phase 2 enzymes. They
hown that fullerenol (polyhydroxylated derivate of C60 fullerene)
retreatment significantly elevated the Nrf 2 expressions, which82 (2011) 69–81
is a key regulator of antioxidant response element-mediated gene
expression and the induction of phase 2 detoxifying enzymes and
elevated activity of g-glutamylcysteine ligase (GCL), which is the
rate-limiting a phase 2 enzyme for GSH synthesis, resulting in an
increase in GSH level.
4.9. Testosterone and cholesterol levels
In the present study, testosterone levels in diabetic rats were
significantly lower compared with control. Our observation on
testosterone level is in agreement with those of previously reported
studies. A decreased level of serum testosterone is reported to
be associated with a decrease in LH, a decrease in the number
of Leydig cells or both in male diabetic rats. Consistently, it is
reported that serum level of LH, responsible for normal Leydig
cell function (testosterone secretion), decreases in diabetes. It was
reported that total Leydig cell number decreases and Leydig cell
function is impaired in diabetes, since due to the lack of insulin,
the insulin-mediated stimulation of androgen biosynthesis and cell
proliferation declines in testicular tissues of diabetic rats, which is
consistent with the histopathological changes in testis observed
(Cameron et al., 1985; Zhao et al., 2010). Mallick et al. (2007) pro-
posed an alternative explanation for low level of testosterone in
diabetes, suggesting that the decrease in serum testosterone in dia-
betes may also be associated with the reduction in the activities
of androgenic key enzymes i.e., 5,3-hydroxysteroid dehydroge-
nase and 17-hydroxysteroid dehydrogenase.
The decreased testosterone level measured in STZ-diabetes
group may also partly be associated with the low level of choles-
terol observed in the current study, since testosterone is derived
from cholesterol (Waterman and Keeney, 1992). Administration of
C60HyFn resulted in a significant elevation of cholesterol level. This
may indicate that hydrated C60 fullerene might promote testos-
terone production by increasing the conversion from cholesterol
to testosterone by Leydig cells.
There is still a debate which type of diabetes has the strongest
impact on the reproductive function in males. Despite adverse
reproductive outcomes of type 1 diabetes have been acknowl-
edged, the research has recently shown that hypogonadism is
also common in middle-aged patients with type 2. It should be
noted that young type 2 diabetic patients have significantly lower
plasma concentrations of total and free testosterone (Chandel
et al., 2008). Considering that the C60HyFn contributed to the
normalization of testosterone level in the blood of STZ-diabetic
rats, it is believed that hydrated fullerene could be an effective
tool for correction of reproductive dysfunction in type 2 diabetes
as well.
4.10. Fatty acids
The phospholipids of testis composed of extremely high pro-
portions of PUFAs (approximately 70% of the fatty acids) with a
prevalence of linoleic (C18:2 n6), arachidonic (C20:4 n6) and docos-
apentaenoic (C22:5 n6) acids (Yin et al., 1999; Gavazza and Catalá,
2001). Many studies suggest that polyenoic acids, particularly
C22:5 n−6 have an important role in the process of spermatoge-
nesis in rats. Altered lipid metabolism is usually associated with
testicular dysfunctions (Coniglio et al., 1977). In the present study,
we observed significant changes in lipid constituents in testis of
diabetic rats. In diabetic testis, biosynthesis of PUFAs is impaired
due to the inhibition of desaturases involved in the desaturation
of fatty acids (Huang et al., 1984). It is also likely that alteration in
fatty acid composition might be associated with low testosterone
level in diabetic animals, since it is reported that testosterone may
be involved in the regulation of biosynthesis of PUFAs and lipids
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The low level of palmitic acid (16:0) observed in the current
tudy in STZ-diabetes group may be associated with insulin insuf-
ciency, since both activities of acetyl CoA carboxylase and fatty
cid synthase are dependent upon the presence of insulin. C60HyFn
ppear to have effects on these enzymes, since treatment of dia-
etic rats with hydrated C60 fullerene increased significantly when
ompared with those of STZ-diabetes group.
Palmitoleic (16:1 n−7) and oleic acids (18:1 n−9) are monoun-
aturated fatty acids, which are biosynthesized from 16:0 and
8:0 as substrate by stearoyl-CoA desaturase (SCD) (Ntambi, 1995).
ctivity of SCD enzyme increases in the presence of insulin. These
atty acids serve as mediators of signal transduction, cellular differ-
ntiation and regulator of apoptosis (Miyazaki et al., 2002).
While levels of arachidonic acid (20:4 n6) and docosapen-
aenoic acid (22:5 n6) were comparable in control and diabetic
ats, C60HyFn treatment in diabetic and nondiabetic rats resulted
n significant elevations of these fatty acids. There are several other
tudies on measurement of arachidonic acid in testis of diabetic
ats, which reports a slight but insignificant decrease in level of
rachidonic acid (Wilder and Coniglio, 1984). Docosapentaenoic
cid (C22:5 n6) has an important role in the process of spermatoge-
esis in the rat (Coniglio et al., 1977). It is known that arachidonic
cid (AA) has an important role in a variety of biological processes,
uch as signal transduction, chemotaxis, cell proliferation, differen-
iation, apoptosis and testicular steroidogenesis (Romanelli et al.,
995). While free fatty acids such as palmitic acids and stearic
cids induced apoptosis of the Leydig cells by ceramide produc-
ion, AA can partly prevent the apoptotic effect induced by free
atty acids (FFAs) (Lu et al., 2003). Furthermore, exogenous AA
auses a dose-dependent increase of testosterone production by
at Leydig cells (Romanelli et al., 1995). It appears that elevations
f arachidonic acid (20:4 n6) and docosapentaenoic acid (22:5 n6)
y C60HyFn treatment are likely to be due to the increase of alpha-
ocopherol as a consequence of C60HyFn administration, which is
eported to suppress the ascorbate–Fe2+-induced lipid peroxida-
ion in rat testis microsomes and mitochondria, protecting the most
UFA, arachidonic [C20:4 n6] and docosapentaenoic [C22:5 n6]
cids from oxidative damage (Gavazza and Catalá, 2001). There-
ore, the increases of arachidonic acid and docosapentaenoic acid
y C60HyFn treatment in the present study may partly explain why
ullerene attenuates the testicular dysfunction and spermatogenic
isruption in the testis induced by diabetes mellitus and why sperm
arameters were much better than that in control.
Results described herein represent novel biological activity
f hydrated neat C60, suggesting that this agent protects male
eproductive system against detrimental influence of uncontrolled
yperglycaemia. Hence, data obtained sufficiently expand our
nowledge concerning involvement of fullerene nanostructures in
rocesses occurring in living matter in health and disease. Because
f their antioxidant properties, fullerenes have been shown to be
nvolved in the inhibition of apoptosis in various cell types includ-
ng neuronal cells (Dugan et al., 1996), hepatoma cells (Huang
t al., 1998), blood mononuclear cells (Monti et al., 2000) and ker-
tinocytes (Fumelli et al., 2000). The biological effects of fullerene
nd its water-soluble derivatives include neuroprotection (Dugan
t al., 2001), radioprotection (Lin et al., 2001), antiproliferative (Lu
t al., 1998), antitumor (Zhu et al., 2008), antiamyloidosis (Podolski
t al., 2007), hepatoprotective (Gharbi et al., 2005), antiarthritis
Yudoh et al., 2009), and antiinflammatory activities (Dellinger
t al., 2009). Besides they inhibit allergic response (Ryan et al.,
007), potentiate hair growth (Zhou et al., 2009), improve cogni-
ive function and increase lifespan of mammals (Quick et al., 2008).
ristine C60 fullerene has prominent potential to attenuate toxi-
ity and to eliminate the increase in the HO-radicals induced by
he coadministration of methamphetamine plus morphine as an
ntiradical agent (Mori et al., 2007). Efficacy of carboxyfullerene82 (2011) 69–81 79
to suppress acrilamide toxicity in human neuroblastoma cells
in vitro (Sumizawa and Igisu, 2009) as well as protective effects
of polyhydroxyfullerene (fullerenol) against doxorubicin-induced
nephro-, pulmo-, cardio-, and hepatotoxicity (Srdjenovic et al.,
2010) in rats have been also attributed to their antioxidant activ-
ity. It is worth to be mentioned that C60HyFn has been recently
demonstrated to be able to inactivate OH-radicals in the num-
ber that substantially exceeds theoretically expected level. It is
postulated that C60HyFn acts as peculiar antioxidant that does
not react with free radicals directly but initiates and catalyzes
the reactions of ROS recombination (dismutation) occurring in
ordered interfacial water shells in the vicinity of fullerene’ sur-
face (thus preserving stability of its own chemical structure against
ROS-induced oxidation) (Andrievsky et al., 2009). This assumption
could explain why C60HyFn exhibits prolonged bioactive effects,
including antioxidant capacity, even in small and super-small
concentrations and doses that has been observed and described
elsewhere (Tykhomyrov et al., 2008; Andrievsky et al., 2005,
2010).
Thanks to the antioxidant properties of fullerenes, there is a
tendency to believe that their biomedical application could be ben-
eficial in the disorders, in which oxidative injury plays a crucial
role in the pathogenesis. To the best of our knowledge currently
there are no reports regarding the effects of non-modified C60
fullerene on reproductive function in mammals. It has been pri-
marily reported that C60 fullerene prevents Fe2+/ascorbate-induced
oxidative stress in goat epididymal spermatozoa in vitro (Murugan
et al., 2002). Also, Andrievsky et al. has been earlier observed that
C60HyFn at concentration range of 1–3 M protects bovine sper-
matozoa against cold shock and increases essentially their viability
following cryoconservation (data not published). Pretreatment of
adult Wistar rats with fullerenol nanoparticles prevented the NO-
induced alterations in the activities of antioxidative enzymes in
interstitial cells of testes (Mirkov et al., 2004). Fullerenol has
been recently observed to exert pronounced testicular-protective
efficacy in preventing oxidative stress induced by doxorubicin
(Srdjenovic et al., 2010). Noteworthy that we have not observed any
signs of fullerene’s spermatoxicity or gonadotoxicity during exper-
imental period. This observation is in accordance with the results
obtained by Mori et al. (2006) who have revealed that pristine
fullerene does not induce acute toxicity in rats even being adminis-
tered per os in the dose of 2000 mg/kg. Because of the involvement
of free radicals in diabetes-induced testicular dysfunction and sper-
matogenic disruption in the testis in STZ-induced animal models of
diabetes mellitus type 1 and in human of both type 1 and type 2, and
administration of C60HyFn to diabetic rats ameliorated the testicu-
lar dysfunction and spermatogenic disruption in the testis induced
by diabetes mellitus in male rats in the current study, hydrated
nanoparticles of unmodified C60 fullerene manifested the superior
antioxidant activity can be used to treat in order to relieve tes-
ticular dysfunction induced by hyperglicaemia in human diabetic
patients.
In conclusion, our results provide preliminary indication that
hydrated nanoparticles of chemically non-modified C60 fullerene
display the superior antioxidant activity necessary to effec-
tively alleviate diabetic complications by elimination of testicular
apoptosis and consequent histopathological abnormalities, thus
resulting in elevation of testosterone level and increase of sperm
content and motility. This protection is most likely mediated by
C60HyFn-induced up-regulation of antioxidant capability of tissues
that, in turn, systemically prevent oxidative damage and maintain
sex hormone levels in diabetic animals. Although further studies
are required to provide new insights into the subtle mechanisms
of tissue-protective effects of water-soluble fullerene nanostruc-
tures, our data persuasively demonstrate for the first time that
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